The FDA granted clearance to Terumo Cardio’s CDI blood parameter monitoring system to monitor oxygen delivery in real-time.
The device is now approved to measure 12 critical blood parameters.
Measuring oxygen delivery is used during cardiopulmonary bypasses to help reduce acute kidney injury, a common complication of cardiac surgery.
